A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanoma

S Nicholson, K Guile, J John, I A Clarke, J Diffley, P Donnellan, A Michael, P Szlosarek, A G Dalgleish

Research output: Contribution to journal › Article › peer-review

24 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences